Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease

Blood

Volumn 87, Issue 3, 1996, Pages 1081-1088

  Yee, Herman Terence ^b   Ponzoni, Maurilio ^b   Merson, Alex ^b   Goldstein, Marsha ^b   Scarpa, Aldo ^b   Chilosi, Marco ^b   Menestrina, Fabio ^b   Pittaluga, Stefania ^b   De Wolf Peeters, Christine ^b   Shiota, Mami ^b   Mori, Shigeo ^b   Frizzera, Glauco ^b   Inghirami, Giorgio ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; NUCLEOPHOSMIN; PHOSPHOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 5; CONTROLLED STUDY; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; NULL CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; T LYMPHOCYTE;

EID: 13344250482     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1081.bloodjournal8731081     Document Type: Article

References (39)

1. Smith CA, Farrah T, Goodwill RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
2. Stein H, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 675
3. Frizzera G: The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin Diag Pathol 9:291, 1992
4. Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli M, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1, 1995
5. Rabbitts T: Chromosomal translocations in human cancer. Nature 372:143, 1994
6. + anaplastic large cell lymphoma: High frequency of c-myc proto-oncogene activation. Blood 83:3581, 1994
7. Le Beau M, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW: The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
8. Kaneko Y, Frizzera G, Edamura S, Maseki N, Sakurai M, Komada Y, Sakurai M, Tanaka H, Sasaki M, Suchi T: A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73:806, 1989
9. Rimokh R, Magaud JP, Berger F, Samarut J, Coiffier B, Germain D, Mason DY: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Hematol 71:31, 1989
10. Ebrahim SA, Ladanyi M, Desai SB, Offit K, Jhanwar SC, Filippa DA, Lieberman PH, Chaganti RS: Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas of uncertain lineage, including twelve Ki-1 positive lymphomas. Genes Chromosom Cancer 2:27, 1990
11. Moms SW, Kirsten MN, Valentine MB, Dittmer KG, Shapiro DN, Slatinan DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
12. Sawyers CL, Denny CT: Chronic myelomonocytic leukemia: Tel-a-Kinase what Ets all about. Cell 77:171, 1994
13. Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R, Cleary M: Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155, 1989
14. Guessow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, Ploegh HL: The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol 139:3132, 1987
15. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ: Analysis of RAS gene mutations, in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 85:1629, 1988
16. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
17. Mason D, Bastrard CRR, Dastugue N, Huret J-L, Kristoffersson U, Magaud J-P, Nezelof C, Tilly H, Vannier J-P, Hemet J, Warnke R: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
18. Sandlund JT, Pui C-H, Roberts WM, Santana VM, Morris SW, Berard CW, Hutcthison RE, Riberio RC, Mahmoud H, Crist WM, Heim M, Raimondi S: Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84.2467, 1994
19. Downing JR, Shurtleff SA, Zielenska M, Curcio BA, Behm FG, Head DR, Sandlund JT, Weisenburger DD, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris SW: Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
20. Rowley J: Chromosomes in Hodgkin's disease. Cancer Treat Rep 66:639, 1982
21. Thangavelu M, Le BMM: Chromosomal abnormalities in Hodgkin's disease. Hematol Oncol Clin North Am 3:221, 1989
22. Sainati L, Montaldi ASM, Putti MC, Zanesco L, Basso G: A novel variant translocation t(2;13)(q23.q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol 75:621, 1990
23. Morgan R, Hecht BKSA, Hecht F, Smith SD: Chromosomal 5q35 breakpoint in malignant histiocytosis. N Engl J Med 312:1322, 1986
24. Soulie J, Rousseau MM, F, Mouly H, Nezelof C: Cytogenetic study of malignant histiocytosis transplanted into nude mice: presence of translocation between chromosomes 5 and 6 and a unique marker (13q;pl). Virch Arch 50:339, 1986
25. Seiff GSF, Spriggs AI: Chromosome changes in Hodgkin's disease. J Natl Cancer Inst 39:557, 1967
26. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
27. Sarris AH, Luthra R, McBride J: The npm gene is rearranged only in a fraction of adult patients with anaplastic large cell lymphoma. Blood 84:2576, 1994
28. Ngan B: The presence of transcripts of the fusion of kinase gene ALK to nucleophosmin gene NPM in the t(2;5) (p23;q35) translocation define subsets of non-Hodgkin's lymphoma with a without CD30 (Ki-1) expression and Hodgkin's disease. Modern Pathol 7:169A, 1995
29. Downing JR, Ladanyi M, Raffeld M, Weiss LM, Morris SW. Large-cell anaplastic lymphoma-specific translocation in Hodkin's disease. Lancet 345:918, 1995
30. Yoneda N, Look ATKM, Valentibe MB, Raimondi SC, Civin CI, Ravindranath Y, Morris SW. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MFL1. Blood 84:440a, 1994 (abstr, suppl 1)
31. De Jong D, Voetdijk BMH, Beverstock GC, Van OG, Villemze R, Kluin P: Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318:1373, 1988
32. Rodriguez GA, Park M: Dimerization mediated through a leucine zipper activates the oncogenic potential of the met tyrosine kinase. Mol Cell Biol 13:6711, 1993
33. Greco A, Pierotti MA, Bongarzone I, Pagliardi S, Lanzi C, Della Porta G: TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes m human papillary thyroid carcinomas. Oncogene 7:227, 1992
34. Shiota M, Fujimoto JST, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9:1567, 1994
35. Lopategui JR, Sun LH, Chan JK, Gaffey MJ, Frierson HJ, Glackin C, Weiss LM: Low frequency associated of the t(2;5) (p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. Am J Pathol 146:323, 1995
36. Orscheschek K, Merz H, Hell J, Binder T, Barteis H, Feller AC: Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's Disease: Indication of a common pathogenesis? Lancet 345:87, 1995
37. Weiss LM, Lopategui JR, Sun LH, Kamel OS, Koo CH, Glackin C: Absence of the t(2;5) in Hodgkin's disease. Blood 85:2845, 1995
38. Ladanyi M, Calvalchire G, Morris SW, Downing J, Filippa DA: Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 145:1296, 1994
39. Chan WC, Elmberger G, Lozano MD, Sanger W, Weisenburger DD: Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 345:920, 1995